Although the plan is simple, its implementation is extremely complex. Medicinal cannabis is a new industry with many unknowns. Legal and reliable seed sources are scarce, cultivation techniques at commercial scale are in a developmental stage, and, as scientific evidence of the medicinal properties of cannabis grows, market demand increases and changes. On top of that the local and international regulatory framework is continuously evolving, and compliance with regulations requires a constant effort of adaptation. We have designed a flexible and adaptable project that fits in this dynamic environment.
Phytotecnia’s approach is a learner’s approach: obtaining and applying existing knowledge and experience from reputable sources, and establishing the mechanisms to obtain new knowledge. As learners, we acknowledge the need to team up with people and entities that can expand our capability. There are rigorous and well-resourced breeding programs around the world, clinical research has a long tradition in countries like Israel, and there are very strong teams working on cannabinoid research. We are developing a network of collaborators while we focus our business on identifying and developing the right products and designing and implementing the cultivation and manufacturing activities that deliver these products.